Article in Zebrafish, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 5 institutions in 2 countries.
Amanda LipsittDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute (GCCRI), UT Health Sciences Center, San Antonio, Texas, USA.ORCID 0000-0002-3757-8493
Nicole R HenschDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute (GCCRI), UT Health Sciences Center, San Antonio, Texas, USA.ORCID 0000-0001-9946-0995
Rodrigo Moreno-CamposDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute (GCCRI), UT Health Sciences Center, San Antonio, Texas, USA.
Kunal BaxiDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute (GCCRI), UT Health Sciences Center, San Antonio, Texas, USA.ORCID 0000-0001-6094-6410
Jiangfei ChenDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute (GCCRI), UT Health Sciences Center, San Antonio, Texas, USA.
Anil K ChallaDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute (GCCRI), UT Health Sciences Center, San Antonio, Texas, USA.ORCID 0000-0002-3633-3304
Eleanor Y ChenDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-4372-7560
Myron S IgnatiusDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute (GCCRI), UT Health Sciences Center, San Antonio, Texas, USA.ORCID 0000-0001-6639-7707
Children's Cancer Center · USThe University of Texas Health Science Center at San Antonio · USUniversity of Alabama at Birmingham · USUniversity of Washington · USWenzhou Medical University · CN
Funding
TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR002645 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2018 to 2022
$20.4M
Cancer Biology Training ProgramT32CA148724 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Pei Wang, Feng-Chun Yang · 2011 to 2026
$3.3M
NRSA Training Core (TL1)TL1TR002647 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHUN, YONG-HEE PATRICIA, FREI, CHRISTOPHER R. · 2018 to 2022
$1.8M
A role for notch in self renewal in embryonal rhabdomyosarcomaR00CA175184 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI IGNATIUS, MYRON STEVE · 2017 to 2019
Angiosarcoma is a clinically aggressive tumor with a high rate of mortality. It can arise in vascular or lymphatic tissues, involve any part of the body, and aggressively spread locally or metastasize. Angiosarcomas spontaneously develop in the
Indexed as
HemangiosarcomaNeoplasm TransplantationZebrafishAnimalsDisease Models, AnimalSuspensionsTumor MicroenvironmentSuspensionsangiosarcomatp53tumor graftzebrafishzebrafish cancer model
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Zebrafish Tumor Graft Transplantation to Grow Tumors · full record | OpenQuestion